Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period

ABSTRACT Many women with bipolar disorder experience episodes of illness or relapses over the perinatal period, especially in the immediate postpartum period. Risks associated with treated/untreated psychopathologies and fetal exposure to bipolar medications make the management of bipolar disorder during these periods challenging for clinicians and patients. In light of the available effectiveness and reproductive safety data, the current clinical update based on the opinions of a group of international perinatal psychiatry authors recommends general considerations and specific management strategies for each possible clinical scenario, including mixed features, predominant polarity, diagnosis of subtypes of bipolar disorder, severity of previous episodes, and risk of recurrence of mood episodes.

[1]  S. Hernández-Díaz,et al.  Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications. , 2023, Journal of women's health.

[2]  O. Howes,et al.  Time to re-evaluate the risks and benefits of valproate and a call for action , 2022, The British Journal of Psychiatry.

[3]  E. Vieta,et al.  Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study , 2022, Archives of Women's Mental Health.

[4]  Stuart J. Watson,et al.  Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital , 2022, Psychiatry Research.

[5]  C. McDougle,et al.  Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. , 2022, JAMA internal medicine.

[6]  L. Forsberg,et al.  Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden , 2022, CNS Drugs.

[7]  C. van Kesteren,et al.  Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review. , 2021, The Journal of clinical psychiatry.

[8]  A. Wikström,et al.  Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study , 2021, BMC Medicine.

[9]  M. Gissler,et al.  Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study , 2021, Evidence-Based Mental Health.

[10]  Sabine J. Roza,et al.  The effect of prenatal lithium exposure on the neuropsychological development of the child , 2021, Bipolar disorders.

[11]  Kenneth K C Man,et al.  Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age , 2021, JAMA internal medicine.

[12]  R. Ophoff,et al.  Bipolar episodes after reproductive events in women with bipolar I disorder, A study of 919 pregnancies. , 2021, Journal of affective disorders.

[13]  S. Hernández-Díaz,et al.  Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. , 2021, The Journal of clinical psychiatry.

[14]  Rachel Vanderkruik,et al.  Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical Antipsychotics , 2021, Archives of Women's Mental Health.

[15]  N. Craddock,et al.  Mood episodes in pregnancy and risk of postpartum recurrence in bipolar disorder: The Bipolar Disorder Research Network Pregnancy Study. , 2021, Journal of affective disorders.

[16]  M. Gissler,et al.  Second-generation antipsychotic use during pregnancy and risk of congenital malformations , 2021, European Journal of Clinical Pharmacology.

[17]  Sean T. Hwang,et al.  Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. , 2021, JAMA neurology.

[18]  D. Blumberger,et al.  Repetitive transcranial magnetic stimulation (rTMS) in bipolar disorder: A systematic review , 2021, Bipolar disorders.

[19]  F. Uguz,et al.  Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study , 2021, Revista brasileira de psiquiatria.

[20]  Kenneth K C Man,et al.  Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: A systematic review and meta‐analysis , 2021, British journal of clinical pharmacology.

[21]  A. Komaroff Aripiprazole and lactation failure: The importance of shared decision making. A case report , 2021, Case reports in women's health.

[22]  S. Hernández-Díaz,et al.  Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics , 2021, Archives of Women's Mental Health.

[23]  Y. Kaplan,et al.  Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications. , 2021, Current neuropharmacology.

[24]  E. A. Whitham,et al.  Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial. , 2021, The Journal of clinical psychiatry.

[25]  A. Young,et al.  Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms , 2020, Bipolar disorders.

[26]  R. Porter,et al.  The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary , 2020, Bipolar disorders.

[27]  Liang Zheng,et al.  Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation , 2020, Clinical Pharmacokinetics.

[28]  K. Deligiannidis,et al.  Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. , 2020, The Journal of clinical psychiatry.

[29]  Kenneth K C Man,et al.  Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis , 2020, Schizophrenia Research.

[30]  A. Kyritsis,et al.  Reproductive health in patients with epilepsy , 2020, Epilepsy & Behavior.

[31]  S. Marwaha,et al.  Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Disorder , 2020, Therapeutic advances in psychopharmacology.

[32]  T. Ikuta,et al.  Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials , 2020, Molecular Psychiatry.

[33]  J. Christensen,et al.  Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones , 2020, JAMA network open.

[34]  P. Lichtenstein,et al.  Antiseizure medication use during pregnancy and risk of ASD and ADHD in children , 2020, Neurology.

[35]  T. Furukawa,et al.  Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis. , 2020, JAMA psychiatry.

[36]  A. McGirr,et al.  The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: A systematic review and meta-analysis. , 2020, Journal of affective disorders.

[37]  F. Uguz Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses , 2020, Expert opinion on drug safety.

[38]  S. Ito,et al.  Infant drug exposure via breast milk , 2020, British journal of clinical pharmacology.

[39]  F. Uguz Neonatal and Childhood Outcomes in Offspring of Pregnant Women Using Antidepressant Medications: A Critical Review of Current Meta‐Analyses , 2020, Journal of clinical pharmacology.

[40]  J. Ungerer,et al.  Lurasidone in lactation: A case study with laboratory and clinical outcomes , 2020, Australian and New Zealand journal of psychiatry (Print).

[41]  V. Bergink,et al.  Management of lithium dosing around delivery: An observational study , 2020, Bipolar disorders.

[42]  R. Ophoff,et al.  Lithium Use during Pregnancy and the Risk of Miscarriage , 2020, Journal of clinical medicine.

[43]  F. Uguz Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature. , 2020, Asian journal of psychiatry.

[44]  O. Spigset,et al.  Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: A systematic critical review and combined analysis. , 2020, Therapeutic drug monitoring.

[45]  Verinder Sharma,et al.  Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice , 2020, Expert review of neurotherapeutics.

[46]  G. Sani,et al.  Perinatal Mixed Affective State: Wherefore Art Thou? , 2020, The Psychiatric clinics of North America.

[47]  F. Oort,et al.  Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure , 2020, Journal of Neurology.

[48]  V. Morgan,et al.  The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study , 2020, The Australian & New Zealand journal of obstetrics & gynaecology.

[49]  Kenneth K C Man,et al.  The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis , 2020, Psychological Medicine.

[50]  K. Meador,et al.  Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. , 2019, JAMA neurology.

[51]  H. Swartz,et al.  The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology , 2019, Bipolar disorders.

[52]  H. Swartz,et al.  Evidence-Based Psychotherapies for Bipolar Disorder. , 2019, Focus.

[53]  C. Ernst,et al.  Psychopharmacological Decision Making in Bipolar Disorder During Pregnancy and Lactation: A Case-by-Case Approach to Using Current Evidence. , 2019, Focus.

[54]  S. Hernández-Díaz,et al.  Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. , 2019, The Journal of clinical psychiatry.

[55]  P. Llorca,et al.  Pharmacotherapy for the peripartum management of bipolar disorder , 2019, Expert opinion on pharmacotherapy.

[56]  C. Tek,et al.  Antipsychotic Exposure in Pregnancy and the Risk of Gestational Diabetes: A Systematic Review and Meta-analysis. , 2019, Schizophrenia bulletin.

[57]  Shuo Zhang,et al.  Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy , 2019, Brain and behavior.

[58]  M. Landén,et al.  Psychoeducation for bipolar disorder and risk of recurrence and hospitalization – a within-individual analysis using registry data , 2019, Psychological Medicine.

[59]  R. Kupka,et al.  Risk of recurrence of mood disorders during pregnancy and the impact of medication: A systematic review. , 2019, Journal of affective disorders.

[60]  D. Bogen,et al.  Risk-Benefit assessment of infant exposure to lithium through breast milk: a systematic review of the literature , 2019, International review of psychiatry.

[61]  F. Uguz A New Safety Scoring System for the Use of Psychotropic Drugs During Lactation. , 2019, American journal of therapeutics.

[62]  F. Uguz Antipsychotic Use During Pregnancy and the Risk of Gestational Diabetes Mellitus: A Systematic Review , 2019, Journal of clinical psychopharmacology.

[63]  A. Young,et al.  Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures , 2019, Behavioural Brain Research.

[64]  Stuart J. Watson,et al.  Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study , 2019, European Neuropsychopharmacology.

[65]  D. Bogen,et al.  Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes. , 2019, Journal of affective disorders.

[66]  V. Bergink,et al.  Lithium during pregnancy and after delivery: a review , 2018, International Journal of Bipolar Disorders.

[67]  Stuart J. Watson,et al.  Aripiprazole and pregnancy: A retrospective, multicentre study. , 2018, Journal of affective disorders.

[68]  A. Young,et al.  Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines , 2018, Acta psychiatrica Scandinavica.

[69]  S. Hernández-Díaz,et al.  Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. , 2018, The American journal of psychiatry.

[70]  Clare L. Taylor,et al.  Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. , 2018, The lancet. Psychiatry.

[71]  Sabine J. Roza,et al.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis , 2018, European Child & Adolescent Psychiatry.

[72]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[73]  S. Vigod,et al.  Breastfeeding and lithium: is breast always best? , 2018, The lancet. Psychiatry.

[74]  P. Videbech,et al.  The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review , 2018, CNS Drugs.

[75]  Verinder Sharma,et al.  Weighing the Risks: the Management of Bipolar Disorder During Pregnancy , 2018, Current Psychiatry Reports.

[76]  Verinder Sharma,et al.  Recurrence of bipolar disorder during pregnancy: a systematic review , 2018, Archives of Women's Mental Health.

[77]  J. Calabrese,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder , 2018, Bipolar disorders.

[78]  G. Parker,et al.  Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? , 2018, Journal of affective disorders.

[79]  A. Fagiolini,et al.  Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. , 2018, Journal of affective disorders.

[80]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder , 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[81]  Lingjiang Li,et al.  Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. , 2017, Journal of affective disorders.

[82]  F. Uguz Prophylactic use of olanzapine and quetiapine from pregnancy to the postpartum period in women with bipolar disorder: a case series , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[83]  S. Wisniewski,et al.  Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. , 2017, The American journal of psychiatry.

[84]  M. Freeman,et al.  Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. , 2017, Psychosomatics.

[85]  S. Patten,et al.  Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies , 2017, Drug Safety.

[86]  S. Kushner,et al.  Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study. , 2017, Journal of affective disorders.

[87]  A. Tricco,et al.  Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis , 2017, BMJ Open.

[88]  S. Kushner,et al.  Lithium dosing strategies during pregnancy and the postpartum period , 2017, British Journal of Psychiatry.

[89]  S. Hernández-Díaz,et al.  Lithium Use in Pregnancy and the Risk of Cardiac Malformations , 2017, The New England journal of medicine.

[90]  A. Young,et al.  British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 , 2017, Journal of psychopharmacology.

[91]  Verinder Sharma,et al.  Peripartum management of bipolar disorder: what do the latest guidelines recommend? , 2017, Expert review of neurotherapeutics.

[92]  R. V. Van Lieshout,et al.  A review of the safety of clozapine during pregnancy and lactation , 2017, Archives of Women's Mental Health.

[93]  C. Dintsios,et al.  Letter to the editor of the Journal of Affective Disorders: Supporting the guideline's quest for real direct costs of depression care. , 2017, Journal of affective disorders.

[94]  E. Larsen,et al.  Pregnancy and bipolar disorder: the risk of recurrence when discontinuing treatment with mood stabilisers: a systematic review , 2016, Acta Neuropsychiatrica.

[95]  A. Young,et al.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm , 2016, The international journal of neuropsychopharmacology.

[96]  A. Serretti,et al.  Bipolar II disorder as a risk factor for postpartum depression. , 2016, Journal of affective disorders.

[97]  C. Begley,et al.  Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes , 2016, BMC Pregnancy and Childbirth.

[98]  A. Carvalho,et al.  Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder , 2016, European Neuropsychopharmacology.

[99]  S. Hernández-Díaz,et al.  Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. , 2016, JAMA psychiatry.

[100]  M. Loane,et al.  The changing epidemiology of Ebstein’s anomaly and its relationship with maternal mental health conditions: a European registry-based study , 2016, Cardiology in the Young.

[101]  F. Uguz Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety , 2016, Journal of clinical psychopharmacology.

[102]  Verinder Sharma,et al.  Mood stabilizers during breastfeeding: a systematic review of the recent literature , 2016, Bipolar disorders.

[103]  F. Uguz A pharmacological approach to panic disorder during pregnancy , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[104]  C. Bowden,et al.  Analysis of bipolar maintenance treatment with lithium versus olanzapine utilizing Multi‐state Outcome Analysis of Treatments (MOAT) , 2016, Bipolar disorders.

[105]  Francesco Salvo,et al.  Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase® , 2016, Drug Safety.

[106]  C. Ernst,et al.  Bipolar Disorder in Pregnancy and Postpartum: Principles of Management , 2016, Current Psychiatry Reports.

[107]  T. Hale,et al.  Drugs in Breast Milk. , 2015, Clinical obstetrics and gynecology.

[108]  S. Wisniewski,et al.  Maternal-Infant interaction in women with unipoloar and bipolar depression. , 2015, Applied nursing research : ANR.

[109]  S. Kushner,et al.  Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis. , 2015, The American journal of psychiatry.

[110]  G. Koren,et al.  Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis , 2015, Journal of clinical psychopharmacology.

[111]  J. Beyene,et al.  Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta‐analysis , 2015, Clinical pharmacology and therapeutics.

[112]  M. Bloch,et al.  Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy , 2015, Obstetrics and gynecology.

[113]  M. Gissler,et al.  Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design , 2015, BMJ : British Medical Journal.

[114]  J. Soares,et al.  Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. , 2015, Revista brasileira de psiquiatria.

[115]  K. Meador,et al.  IQ at 6 years after in utero exposure to antiepileptic drugs , 2015, Neurology.

[116]  A. Marson,et al.  Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. , 2014, The Cochrane database of systematic reviews.

[117]  H. Kapfhammer,et al.  Clinical course of illness in women with early onset puerperal psychosis: a 12-year follow-up study. , 2014, The Journal of clinical psychiatry.

[118]  A. Wieringa,et al.  Concentrations of venlafaxine and its main metabolite O‐desmethylvenlafaxine during pregnancy , 2014, Journal of clinical pharmacy and therapeutics.

[119]  A. Kilbourne,et al.  Self-Management and Bipolar Disorder–A Clinician’s Guide to the Literature 2011-2014 , 2014, Current Psychiatry Reports.

[120]  K. Meador,et al.  Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. , 2014, JAMA pediatrics.

[121]  O. Spigset,et al.  Transfer of aripiprazole to breast milk: a case report. , 2014, Journal of clinical psychopharmacology.

[122]  M. Freeman,et al.  Pharmacotherapy for Mood Disorders in Pregnancy: A Review of Pharmacokinetic Changes and Clinical Recommendations for Therapeutic Drug Monitoring , 2014, Journal of clinical psychopharmacology.

[123]  S. Gentile Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions , 2014, CNS Spectrums.

[124]  L. Tata,et al.  Sex prevalence of major congenital anomalies in the United Kingdom: A national population-based study and international comparison meta-analysis , 2014, Birth defects research. Part A, Clinical and molecular teratology.

[125]  G. Maina,et al.  Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women , 2014, Archives of Women's Mental Health.

[126]  N. Delanty,et al.  Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[127]  Verinder Sharma,et al.  Pharmacotherapy of bipolar II disorder during and after pregnancy. , 2013, Current drug safety.

[128]  A. Allignol,et al.  Atypical Antipsychotic Drugs and Pregnancy Outcome: A Prospective, Cohort Study , 2013, Journal of clinical psychopharmacology.

[129]  N. Craddock,et al.  Perinatal episodes across the mood disorder spectrum. , 2013, JAMA psychiatry.

[130]  L. Brandt,et al.  Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study , 2012, BMJ : British Medical Journal.

[131]  Verinder Sharma,et al.  Pregnancy and bipolar disorder: a systematic review. , 2012, The Journal of clinical psychiatry.

[132]  S. Kushner,et al.  Prevention of postpartum psychosis and mania in women at high risk. , 2012, The American journal of psychiatry.

[133]  D. Bogen,et al.  Three cases of lithium exposure and exclusive breastfeeding , 2012, Archives of Women's Mental Health.

[134]  R. Baldessarini,et al.  Episodes of mood disorders in 2,252 pregnancies and postpartum periods. , 2011, The American journal of psychiatry.

[135]  C. Esmer,et al.  Severe consequences of carbamazepine exposure in utero , 2011, BMJ Case Reports.

[136]  R. Kessler,et al.  Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. , 2011, Archives of general psychiatry.

[137]  K. Meador,et al.  Effects of breastfeeding in children of women taking antiepileptic drugs , 2010, Neurology.

[138]  D. Wildgruber,et al.  Aripiprazole in pregnancy and lactation: a case report. , 2010, Journal of clinical psychopharmacology.

[139]  Verinder Sharma,et al.  Bipolar II postpartum depression: Detection, diagnosis, and treatment. , 2009, The American journal of psychiatry.

[140]  W. Henrich,et al.  Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period , 2009, Epilepsy Research.

[141]  T. Kircher,et al.  Low concentration of ziprasidone in human milk: a case report. , 2009, The international journal of neuropsychopharmacology.

[142]  Jonathan Green,et al.  The impact of maternal psychopathology on child–mother attachment , 2009, Archives of Women's Mental Health.

[143]  E. Holmes,et al.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology , 2009, Journal of psychopharmacology.

[144]  Melinda F. Davis,et al.  Pharmacokinetics of Sertraline Across Pregnancy and Postpartum , 2008, Journal of clinical psychopharmacology.

[145]  Mark Olfson,et al.  Psychiatric disorders in pregnant and postpartum women in the United States. , 2008, Archives of general psychiatry.

[146]  P. Pennell,et al.  Lamotrigine in Breast Milk and Nursing Infants: Determination of Exposure , 2008, Pediatrics.

[147]  N. Craddock,et al.  Early postpartum symptoms in puerperal psychosis , 2008, BJOG : an international journal of obstetrics and gynaecology.

[148]  R. Baldessarini,et al.  Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. , 2007, The American journal of psychiatry.

[149]  R. Baldessarini,et al.  Lithium in breast milk and nursing infants: clinical implications. , 2007, The American journal of psychiatry.

[150]  K. Kendrick,et al.  Quetiapine Augmentation in Lactation: A Series of Case Reports , 2006, Journal of clinical psychopharmacology.

[151]  Verinder Sharma,et al.  Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. , 2006, Bipolar disorders.

[152]  A. Serretti,et al.  Influence of postpartum onset on the course of mood disorders , 2006 .

[153]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[154]  M. Clementi,et al.  Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. , 2005, The Journal of clinical psychiatry.

[155]  B. Hanusa,et al.  Prevention of postpartum episodes in women with bipolar disorder , 2004, Biological Psychiatry.

[156]  S. Vahip,et al.  Risk Factors Associated with Childbearing-Related Episodes in Women with Bipolar Disorder , 2003, Psychopathology.

[157]  G. Koren,et al.  Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. , 2003 .

[158]  P. Keck,et al.  The impact of reproductive events on the course of bipolar disorder in women. , 2002, The Journal of clinical psychiatry.

[159]  M. Alda,et al.  Protective effect of pregnancy in women with lithium-responsive bipolar disorder. , 2000, Journal of affective disorders.

[160]  T. Tomson,et al.  Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During Lactation , 2000, Epilepsia.

[161]  R. Baldessarini,et al.  Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. , 2000, The American journal of psychiatry.

[162]  G. Devore,et al.  The aortic and pulmonary outflow tract screening examination in the human fetus , 1992, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[163]  A. Young,et al.  Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. , 2019, The American journal of psychiatry.

[164]  E. Barzilay,et al.  Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis , 2017, CNS Drugs.

[165]  B. Hanusa,et al.  Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. , 2013, JAMA psychiatry.

[166]  M. Loane,et al.  The prevalence of congenital anomalies in Europe. , 2010, Advances in experimental medicine and biology.

[167]  T. Einarson,et al.  Long-Term Developmental Outcome of Children of Women with Epilepsy, Unexposed or Exposed Prenatally to Antiepileptic Drugs , 2010, Drug safety.

[168]  G. Anderson Pregnancy-Induced Changes in Pharmacokinetics , 2005, Clinical pharmacokinetics.